Zante Greg (CIK 0001264949)

Latest company ownership

Shares held
173,592
Last filed at
Oct 28, 2025
Confidence Score
84.7
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 27, 2025 Oct 28, 2025 Viking Therapeutics, Inc. CFO Sell 87.5 +4,932 2.92% $216.5K
Jul 2, 2025 Jul 3, 2025 Viking Therapeutics, Inc. CFO Sell 82.5 +3,401 2.06% $118.4K
Jan 3, 2025 Jan 6, 2025 Viking Therapeutics, Inc. CFO Sell 100.0 +15,891 10.64% $2.2M
Oct 28, 2024 Oct 28, 2024 Viking Therapeutics, Inc. CFO Sell 2.5 -131,687 -46.85% $10.1M
Jul 29, 2024 Jul 31, 2024 Viking Therapeutics, Inc. CFO Sell 92.5 +12,198 6.98% $922.2K
May 3, 2024 May 3, 2024 Viking Therapeutics, Inc. CFO Sell 5.0 -66,756 -27.63% $5M
Mar 27, 2024 Mar 27, 2024 Viking Therapeutics, Inc. CFO Sell 95.0 +15,057 7.83% $1.4M
Mar 1, 2024 Mar 4, 2024 Viking Therapeutics, Inc. CFO Sell 95.0 +11,574 6.40% $1.7M
Jan 3, 2024 Jan 4, 2024 Viking Therapeutics, Inc. CFO Sell 100.0 +20,340 12.68% $1.4M
Apr 17, 2023 Apr 18, 2023 Viking Therapeutics, Inc. CFO Sell 37.5 -7,500 -4.78% $150K
Apr 11, 2023 Apr 13, 2023 Viking Therapeutics, Inc. CFO Sell 10.0 -97,839 -24.68% $1.8M
Mar 30, 2023 Apr 3, 2023 Viking Therapeutics, Inc. CFO Sell 15.0 -160,439 -19.81% $3.8M
Dec 30, 2022 Jan 4, 2023 Viking Therapeutics, Inc. CFO Sell 97.5 +46,562 33.62% $563.4K
Jan 3, 2022 Jan 5, 2022 Viking Therapeutics, Inc. CFO Sell 95.0 +41,401 43.62% $55.9K
Sep 28, 2021 Sep 30, 2021 Viking Therapeutics, Inc. CFO Sell 83.8 +4,361 4.84% $15K
Jan 19, 2021 Jan 19, 2021 Viking Therapeutics, Inc. CFO Sell 50.0 -808 -0.89% $5.4K
Jan 4, 2021 Jan 6, 2021 Viking Therapeutics, Inc. CFO Sell 91.3 +68,663 313.59% $16.2K